Stand down flaccid penis, the next fat profit center in the pharmaceutical industry may be the double chin.
Allergan Plc is beginning an aggressive sales blitz for Kybella, the first injectable treatment for what the medical industry terms “submental fat” and you probably think of as the junk inside of jowls. “It’s a disruptive technology,” said Philippe Schaison, president of Allergan’s U.S. medical business. “It’s working great, and there’s nothing like it.”
